Table 3.
Awareness of pharmacovigilance centres and reporting status of HCPs between the intervention and control groups, before and after the intervention, n (%).
| Preintervention |
Postintervention |
|||||
|---|---|---|---|---|---|---|
| Intervention (n = 524) | Control (n = 287) |
p value | Intervention (n = 596) | Control (n = 335) | p value | |
| Awareness of the local pharmacovigilance centre | 322 (61.5) | 77 (26.8) | <0.001 | 345 (57.9) | 135 (40.3) | <0.001 |
| Awareness of the SSZPC | 162 (30.9) | 54 (18.9) | <0.001 | 273 (45.8) | 78 (23.3) | <0.001 |
| Awareness of the NPC | 282 (53.8) | 128 (45.1) | 0.054 | 294 (49.3) | 198 (59.1) | 0.009 |
| Awareness of the ADR reporting form | 199 (38.0) | 84 (26.6) | 0.047 | 290 (48.7) | 63 (18.8) | <0.001 |
| Doctors to report | 481 (91.8) | 267 (93.0) | 0.737 | 517 (86.7) | 315 (94.0) | 0.006 |
| Nurses to report | 467 (89.1) | 258 (89.9) | 0.755 | 498 (83.6) | 305 (91.0) | 0.006 |
| Pharmacists to report | 472 (90.4) | 261 (90.9) | 0.610 | 531 (89.1) | 311 (92.8) | 0.030 |
p value from Pearson chi-square test.
Bold numerals indicate significance.
ADR, Adverse Drug Reaction; HCPs, healthcare professionals; NPC, National Pharmacovigilance Centre; SSZPC, South-South Zonal Pharmacovigilance Centre.